Cargando…
Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study
OBJECTIVES: To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predictive of worsening information processing speed (IPS) as measured by Symbol Digit Modalities Test (SDMT). METHODS: Demographic, clinical data and 1.5 T MRI scans were collected in 76 patients at time o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876764/ https://www.ncbi.nlm.nih.gov/pubmed/33623706 http://dx.doi.org/10.1177/2055217321992394 |
_version_ | 1783650033513529344 |
---|---|
author | Jacobsen, Cecilie Zivadinov, Robert Myhr, Kjell-Morten Dalaker, Turi O Dalen, Ingvild Benedict, Ralph HB Bergsland, Niels Farbu, Elisabeth |
author_facet | Jacobsen, Cecilie Zivadinov, Robert Myhr, Kjell-Morten Dalaker, Turi O Dalen, Ingvild Benedict, Ralph HB Bergsland, Niels Farbu, Elisabeth |
author_sort | Jacobsen, Cecilie |
collection | PubMed |
description | OBJECTIVES: To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predictive of worsening information processing speed (IPS) as measured by Symbol Digit Modalities Test (SDMT). METHODS: Demographic, clinical data and 1.5 T MRI scans were collected in 76 patients at time of inclusion, and after 5 and 10 years. Global and tissue-specific volumes were calculated at each time point. For the primary outcome of analysis, SDMT was used. RESULTS: Worsening SDMT at 5-year follow-up was predicted by baseline age, Expanded Disability Status Scale (EDSS), SDMT, whole brain volume (WBV) and T2 lesion volume (LV), explaining 30.2% of the variance of SDMT. At 10-year follow-up, age, EDSS, grey matter volume (GMV) and T1 LV explained 39.4% of the variance of SDMT change. CONCLUSION: This longitudinal study shows that baseline MRI-markers, demographic and clinical data can help predict worsening IPS. Identification of patients at risk of IPS decline is of importance as follow-up, treatment and rehabilitation can be optimized. |
format | Online Article Text |
id | pubmed-7876764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-78767642021-02-22 Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study Jacobsen, Cecilie Zivadinov, Robert Myhr, Kjell-Morten Dalaker, Turi O Dalen, Ingvild Benedict, Ralph HB Bergsland, Niels Farbu, Elisabeth Mult Scler J Exp Transl Clin Original Research Paper OBJECTIVES: To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predictive of worsening information processing speed (IPS) as measured by Symbol Digit Modalities Test (SDMT). METHODS: Demographic, clinical data and 1.5 T MRI scans were collected in 76 patients at time of inclusion, and after 5 and 10 years. Global and tissue-specific volumes were calculated at each time point. For the primary outcome of analysis, SDMT was used. RESULTS: Worsening SDMT at 5-year follow-up was predicted by baseline age, Expanded Disability Status Scale (EDSS), SDMT, whole brain volume (WBV) and T2 lesion volume (LV), explaining 30.2% of the variance of SDMT. At 10-year follow-up, age, EDSS, grey matter volume (GMV) and T1 LV explained 39.4% of the variance of SDMT change. CONCLUSION: This longitudinal study shows that baseline MRI-markers, demographic and clinical data can help predict worsening IPS. Identification of patients at risk of IPS decline is of importance as follow-up, treatment and rehabilitation can be optimized. SAGE Publications 2021-02-08 /pmc/articles/PMC7876764/ /pubmed/33623706 http://dx.doi.org/10.1177/2055217321992394 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/ Creative Commons CC-BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Paper Jacobsen, Cecilie Zivadinov, Robert Myhr, Kjell-Morten Dalaker, Turi O Dalen, Ingvild Benedict, Ralph HB Bergsland, Niels Farbu, Elisabeth Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study |
title | Brain atrophy and clinical characteristics predicting SDMT
performance in multiple sclerosis: A 10-year follow-up study |
title_full | Brain atrophy and clinical characteristics predicting SDMT
performance in multiple sclerosis: A 10-year follow-up study |
title_fullStr | Brain atrophy and clinical characteristics predicting SDMT
performance in multiple sclerosis: A 10-year follow-up study |
title_full_unstemmed | Brain atrophy and clinical characteristics predicting SDMT
performance in multiple sclerosis: A 10-year follow-up study |
title_short | Brain atrophy and clinical characteristics predicting SDMT
performance in multiple sclerosis: A 10-year follow-up study |
title_sort | brain atrophy and clinical characteristics predicting sdmt
performance in multiple sclerosis: a 10-year follow-up study |
topic | Original Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876764/ https://www.ncbi.nlm.nih.gov/pubmed/33623706 http://dx.doi.org/10.1177/2055217321992394 |
work_keys_str_mv | AT jacobsencecilie brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT zivadinovrobert brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT myhrkjellmorten brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT dalakerturio brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT daleningvild brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT benedictralphhb brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT bergslandniels brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy AT farbuelisabeth brainatrophyandclinicalcharacteristicspredictingsdmtperformanceinmultiplesclerosisa10yearfollowupstudy |